FDA Inspection 1036712 — Shilpa Medicare Limited
The FDA completed an inspection of Shilpa Medicare Limited on Nov 30, 2017 in Jadcherla, Mahabubnagar District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 30, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jadcherla, Mahabubnagar District (India)